Logo image of ARIZ

ARISZ ACQUISITION CORP (ARIZ) Stock Fundamental Analysis

NASDAQ:ARIZ - Nasdaq - US0404501084 - Common Stock - Currency: USD

6.03  -2.22 (-26.91%)

After market: 6.79 +0.76 (+12.6%)

Fundamental Rating

1

ARIZ gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ARIZ may be in some trouble as it scores bad on both profitability and health. ARIZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARIZ had positive earnings in the past year.
ARIZ had a negative operating cash flow in the past year.
ARIZ Yearly Net Income VS EBIT VS OCF VS FCFARIZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K 1M

1.2 Ratios

Industry RankSector Rank
ROA 3.2%
ROE 3.94%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)1.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARIZ Yearly ROA, ROE, ROICARIZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 1 -1 2 3 4

1.3 Margins

ARIZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARIZ Yearly Profit, Operating, Gross MarginsARIZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

ARIZ has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ARIZ has a worse debt to assets ratio.
ARIZ Yearly Shares OutstandingARIZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
ARIZ Yearly Total Debt VS Total AssetsARIZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 1.96 indicates that ARIZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.10 indicates that ARIZ is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 1.96
ROIC/WACCN/A
WACCN/A
ARIZ Yearly LT Debt VS Equity VS FCFARIZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

ARIZ has a Current Ratio of 0.06. This is a bad value and indicates that ARIZ is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.06 indicates that ARIZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
ARIZ Yearly Current Assets VS Current LiabilitesARIZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

ARIZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1662.00%, which is quite impressive.
EPS 1Y (TTM)1662%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARIZ Yearly Revenue VS EstimatesARIZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
ARIZ Yearly EPS VS EstimatesARIZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 37.69 indicates a quite expensive valuation of ARIZ.
The average S&P500 Price/Earnings ratio is at 29.62. ARIZ is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 37.69
Fwd PE N/A
ARIZ Price Earnings VS Forward Price EarningsARIZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARIZ Per share dataARIZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARIZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARISZ ACQUISITION CORP

NASDAQ:ARIZ (2/29/2024, 8:24:35 PM)

After market: 6.79 +0.76 (+12.6%)

6.03

-2.22 (-26.91%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.4%
Inst Owner Change0%
Ins Owners39.45%
Ins Owner Change0%
Market Cap26.41M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 37.69
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)0.16
EY2.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0
BVpS6.51
TBVpS6.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.2%
ROE 3.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)1.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 1.96
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1662%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.53%
OCF growth 3YN/A
OCF growth 5YN/A